The Notch Signalling Pathway: Its Steps and Impacts

Notch signalling pathway review

The Notch signalling pathway is a highly conserved intercellular signalling pathway that regulates various cellular processes. The Notch receptor is a transmembrane protein that is activated by the binding of Notch ligands, which are secreted proteins. There are four known Notch ligands: Jagged, Delta, Serrate, and Lag-related protein. Notch receptors are activated by the binding of a Notch ligand to the receptor's extracellular domain. This binding results in the proteolytic cleavage of the receptor by furin-like proteases. The cleaved Notch intracellular domain (NICD) of the receptor translocates to the nucleus where it interacts with transcription complexes containing CBF1/RBPjk/Su(H)/Lag1 (CSL). Notch signalling has been implicated in many cellular processes such as cell proliferation, apoptosis, differentiation, and migration. Notch signalling has also been shown to impact the expression of genes involved in cancer.

Types of notch signalling

There are two types of Notch signalling: canonical and non-canonical. The canonical pathway is the best-characterized Notch signalling pathway and it involves the activation of the Notch receptor by the binding of Notch ligands. The non-canonical pathway is less well-characterized but it is thought to involve the direct interaction of Notch proteins with transcription factors..

Canonical notch signalling pathway

The canonical Notch signalling pathway is the best-characterized Notch signalling pathway. It involves the activation of the Notch receptor by the binding of Notch ligands, Delta-like (Dll) proteins. This interaction results in the recruitment of the intracellular domain (NICD) of Notch to the cell membrane. NICD is then cleaved by proteases, resulting in its release from the cell membrane. NICD translocates to the nucleus where it binds to Notch transcription factors, such as CBF-A and RBP-Jkappa; and activates transcriptional regulators, such as CSL proteins. This leads to the upregulation of genes involved in cell proliferation and the downregulation of genes involved in cell differentiation. This interaction leads to the activation of Notch target genes, such as Hes and Hey genes. Notch signalling has been shown to be important for embryonic development, stem cell maintenance, and cancer.

Non-canonical Notch signalling

The non-canonical signalling pathway is less well characterized. It is thought to involve the direct interaction of Notch proteins with transcription factors, such as TCF/LEF proteins. This interaction leads to the activation of Notch target genes, such as Hes and Hey genes.

Notch Delta signalling pathway

The Notch Delta Signalling pathway is a non-canonical Notch signalling pathway that involves the direct interaction of Notch proteins with transcription factors. The Notch Delta Signalling pathway has been implicated in various forms of cancer. For example, it has been shown to promote cell proliferation and survival and inhibit the differentiation of cancer cells.

Notch signalling pathway and cancer 

Notch signalling has been implicated in many forms of cancer. Notch signalling is thought to promote cancer by upregulating the expression of genes involved in cell proliferation and downregulating the expression of genes involved in cell differentiation. Notch signalling has also been shown to impact the expression of genes involved in metastasis. For example, Notch signalling has been shown to promote epithelial-mesenchymal transition (EMT) and invasion. Notch signalling has been shown to be upregulated in various types of cancers, including breast, lung, pancreatic, and ovarian cancers.

Notch signalling and leukaemia

Notch signalling has been shown to be upregulated in various types of leukaemia, including adult T cell acute lymphoblastic leukaemia and lymphoma. Notch receptor activation mutations that result in nuclear accumulation of NICD are prevalent in adult T cell acute lymphoblastic leukaemia and lymphoma.

Notch signalling in disease

Notch signalling has been implicated in many diseases. Loss-of-function Notch receptor and ligand mutations are associated with numerous diseases, including Alagille syndrome and CADASIL, an autosomal dominant form of cerebral arteriopathy.

Notch Signalling in Development

Embryo polarity and Notch signalling

Notch signalling is essential for the correct orientation of the embryo. Notch signalling is required to establish and maintain polarity in the early embryo. Notch signalling regulates polarity by controlling the activity of transcription factors, such as EZH and PcG proteins.

Notch signalling is essential to correct embryonic patterning and for the formation of tissues and organs. Notch signalling is also required for the establishment of left-right symmetry in the embryo. Notch signalling regulates left-right symmetry by controlling the activity of transcription factors, such as Nodal and Wnt proteins. Notch signalling has been implicated in various human diseases, including heterotaxy and situs ambiguus.

Notch signalling and stem cells

Notch signalling is required for the maintenance of stem cells. Notch signalling regulates stem cell renewal by controlling the activity of transcription factors, such as Sox and Oct proteins. Notch signalling has also been shown to regulate self-renewal and differentiation of embryonic stem cells.

Notch singalling and cell fate

The Notch pathway plays a role in specifying cell fate during embryonic development. Notch signalling is thought to promote differentiation by upregulating the expression of genes involved in cell differentiation and downregulating the expression of genes involved in proliferation. Notch signalling regulates stem cell fate by controlling the activity of transcription factors, such as Oct-IV and Nanog. Notch signalling controls cell proliferation, cell survival, cell migration, and cell differentiation.

Notch signalling and adult tissue homeostasis

Notch signalling is required for the maintenance of adult tissue homeostasis. Notch signalling regulates cell proliferation and cell fate in various tissues, including the skin, intestine, and nervous system. Notch signalling is thought to promote cell proliferation by upregulating the expression of genes involved in cell proliferation and downregulating the expression of genes involved in cell differentiation. For example, Notch signalling has been shown to promote hair follicle regeneration and intestinal stem cell renewal.

Notch signalling and adult brain development

Notch signalling is required for the normal development of the adult brain. Notch signalling regulates neurogenesis, synaptogenesis, and plasticity in the adult brain. Notch signalling has been shown to promote neurogenesis by upregulating the expression of genes involved in neurogenesis and downregulating the expression of genes involved in cell differentiation. Notch signalling has also been shown to impact synaptic function and plasticity by regulating gene expression.

Notch signalling and gene expression

Notch signalling has been shown to regulate gene expression. For example, Notch signalling has been shown to upregulate the expression of genes involved in cell proliferation and downregulate the expression of genes involved in cell differentiation. Notch signalling has also been shown to impact the expression of genes involved in cancer. Notch signalling regulates gene expression by upregulating the activity of transcription factors, such as c-Myc, cyclin D, and Notch-related proteins. Notch signalling has also been shown to downregulate the activity of transcription factors, such as p53 and RB.

Notch signalling inhibitor

Inhibitors of notch signalling include Notch-specific antibodies, Notch ligand traps, and Notch inhibitors. Notch inhibitors are small molecule compounds that block the activation of the Notch receptor. Notch inhibitors are being investigated as potential treatments for cancer.

Related products